期刊文献+

硫酸羟氯喹治疗风湿病的疗效分析 被引量:2

下载PDF
导出
摘要 目的:评价硫酸羟氯喹治疗风湿病的疗效。方法选取2009年7月~2012年7月海丰县彭湃纪念医院收治的风湿病患者(主要为RA和痛风性关节炎患者)120例为研究对象,随机均分为2组(n=60)。对照组采用柳氮磺砒啶与甲氨蝶呤治疗,观察组同时采用硫酸羟氯喹治疗,对比治疗前后2组临床相关指标的变化情况、综合疗效以及不良反应发生情况。结果观察组关节肿胀数、关节压痛数、疼痛程度以及CRP几项指标均改善更显著;观察组总有效率91.7%,对照组仅为76.7%;2组不良情况出现率均为3.3%;综合疗效对比显示观察组明显更优(P<0.05)。结论硫酸羟氯喹应用于风湿病的治疗的过程中,疗效确切,且具有较高的安全性,适合在临床推广。 Objective To assess the curative effect of hydroxychloroquine sulfate in the treatment of rheumatism. Methods 120 cases of patients with rheumatism(mainly for patients with RA and gouty arthritis)from July 2009 to July 2012, were randomly divided into two groups. the control group (n=60) use willow nitrogen cycling arsenic organism and methotrexate, the experimental group (n=60) were cured by hydroxychloroquine sulfate at the same time, Compared two groups changes of clinically relevant indicators before and after treatment, comprehensive curative effect and adverse conditions. Results The observation group joint swelling, joint tenderness, degree of pain and CRP indicators was more significantly;The observation group total efficiency were 91.7%, the control group total efficiency were 76.7%, the two groups adverse reactions rate were all 3.3%;The comprehensive curative effect comparison showed that the observation group was significantly better (P〈0.05). Conclusion Hydroxychloroquine sulfate applys in treatment of rheumatism is definite efficacy, and has higher security, Is suitable for clinical promotion.
作者 胡壮彬
出处 《当代医学》 2014年第11期7-8,共2页 Contemporary Medicine
关键词 硫酸羟氯喹 风湿病 疗效 Hydroxychloroquine sulfate Rheumatism Curative effect
  • 相关文献

参考文献5

二级参考文献48

  • 1Ulrik Baandrup.Rheumatic fever reappraised[J].Chinese Medical Journal,2005(5):360-361. 被引量:6
  • 2Tirri G,Montagna G,Salaffi F,et al.Combination therapy with cyclosporin and hydroxychloroquine in early active severe rheumatoid arthritis[R].Abstracts of the ACR 1997 national meeting:397.
  • 3Fox RI,Dixon R,Guarrasi V,et al.Treatment of primary Sjogren's syndrome with hydroxychloroquine:a retrospective,open-label study[J].Lupus,1996,5 (Suppl 1):S31-S36.
  • 4Dawson LJ,Caulfied VL,Stanbury JB,et al.Hydroxychloroquine therapy in patients with primary Sjogren's syndrome may improve salivary gland hypofunctionby inhibition of glandular cholinesterase[J].Rheumatology,2005,44(4):449-455.
  • 5Bertsias G,Ioannidis JP,Boletis J,et al.EULAR recommendations for the management of systemic lupus erythematosus.Report of a Task Force of the EULAR StandingCommittee for International Clinical Studies IncludingTherapeutics[J].Ann Rheum Dis,2010,67 (2):195-196.
  • 6Costedoat-Chalumeau N,Leroux G,Piette JC,et al.Why all systemic lupus erythematosus patients should be given hydroxychloroquine treatment[J] ? Joint Bone Spine,2010,77(1):4-5.
  • 7Ang GC,Werth VP.Combination antimalarials in the treatment of cutaneous dermatomyositis[J].Archives of Dermatology,2005,141 (7):855-859.
  • 8Marguerie L,Flipo RM,Grardel B,et al.Use of disease modifying antirheumatic drugs in patients with psoriatic arthritis[J].Joint Bone Spine,2002,69 (3):275-281.
  • 9James JA,Kim-Howard XR,Bruner BF,et al.Hydroxychloroquine sulfate treatment is associated withlater onset of systemic lupus erythematosus[J].Lupus,2007:16(6):401-409.
  • 10Jessop S,Whitelaw D,Jordaan F.Drugs for discoid lupus erythematosus[CD].Cochrane database of systematic reviews(Online)2001(1):CD002954.

共引文献34

同被引文献9

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部